Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Leukocytapheresis for treatment of IBD.
Kohgo Y, Ashida T, Maemoto A, Ayabe T. Kohgo Y, et al. Among authors: maemoto a. J Gastroenterol. 2003 Mar;38 Suppl 15:51-4. J Gastroenterol. 2003. PMID: 12698872 Review.
Expression of the antimicrobial peptide alpha-defensin/cryptdins in intestinal crypts decreases at the initial phase of intestinal inflammation in a model of inflammatory bowel disease, IL-10-deficient mice.
Inaba Y, Ashida T, Ito T, Ishikawa C, Tanabe H, Maemoto A, Watari J, Ayabe T, Mizukami Y, Fujiya M, Kohgo Y. Inaba Y, et al. Among authors: maemoto a. Inflamm Bowel Dis. 2010 Sep;16(9):1488-95. doi: 10.1002/ibd.21253. Inflamm Bowel Dis. 2010. PMID: 20222124
[Recent advance in MRI of Crohn's disease].
Ashida T, Maemoto A, Orii F, Kageyama H. Ashida T, et al. Among authors: maemoto a. Nihon Shokakibyo Gakkai Zasshi. 2010 Jun;107(6):863-7. Nihon Shokakibyo Gakkai Zasshi. 2010. PMID: 20530921 Review. Japanese. No abstract available.
[Clinicopathological study of acute esophageal mucosal lesion].
Kawauchi H, Ohta T, Matsubara Y, Yoshizaki K, Sakamoto J, Amitsuka H, Kimura K, Maemoto A, Orii F, Ashida T. Kawauchi H, et al. Among authors: maemoto a. Nihon Shokakibyo Gakkai Zasshi. 2013 Jul;110(7):1249-57. Nihon Shokakibyo Gakkai Zasshi. 2013. PMID: 23831655 Japanese.
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group. Feagan BG, et al. N Engl J Med. 2016 Nov 17;375(20):1946-1960. doi: 10.1056/NEJMoa1602773. N Engl J Med. 2016. PMID: 27959607 Free article. Clinical Trial.
56 results